Proposed diagnostic algorithm for patients with suspected mastocytosis: a proposal of the European Competence Network on Mastocytosis
Open Access
- 19 May 2014
- Vol. 69 (10), 1267-1274
- https://doi.org/10.1111/all.12436
Abstract
Mastocytosis is an emerging differential diagnosis in patients with more or less specific mediator‐related symptoms. In some of these patients, typical skin lesions are found and the diagnosis of mastocytosis can be established. In other cases, however, skin lesions are absent, which represents a diagnostic challenge. In the light of this unmet need, we developed a diagnostic algorithm for patients with suspected mastocytosis. In adult patients with typical lesions of mastocytosis in the skin, a bone marrow (BM) biopsy should be considered, regardless of the basal serum tryptase concentration. In adults without skin lesions who suffer from mediator‐related or other typical symptoms, the basal tryptase level is an important parameter. In those with a slightly increased tryptase level, additional investigations, including a sensitive KIT mutation analysis of blood leucocytes or measurement of urinary histamine metabolites, may be helpful. In adult patients in whom (i) KIT D816V is detected and/or (ii) the basal serum tryptase level is clearly increased (>25–30 ng/ml) and/or (iii) other clinical or laboratory features suggest the presence of ‘occult’ mastocytosis or another haematologic neoplasm, a BM investigation is recommended. In the absence of KIT D816V and other signs or symptoms of mastocytosis or another haematopoietic disease, no BM investigation is required, but the clinical course and tryptase levels are monitored in the follow‐up. In paediatric patients, a BM investigation is usually not required, even if the tryptase level is increased. Although validation is required, it can be expected that the algorithm proposed herein will facilitate the management of patients with suspected mastocytosis and help avoid unnecessary referrals and investigations.Keywords
This publication has 47 references indexed in Scilit:
- Diagnosis, progression patterns and prognostication in mastocytosisExpert Review of Hematology, 2012
- Pathogenesis, classification and treatment of mastocytosis: state of the art in 2010 and future perspectivesExpert Review of Hematology, 2010
- WHO subvariants of indolent mastocytosis: clinical details and prognostic evaluation in 159 consecutive adultsBlood, 2010
- Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factorsBlood, 2009
- Mast cells and mastocytosisBlood, 2008
- Mastocytosis: State of the ArtPathobiology, 2007
- Standards and standardization in mastocytosis: Consensus Statements on Diagnostics, Treatment Recommendations and Response CriteriaEuropean Journal of Clinical Investigation, 2007
- Diagnosis and classification of mast cell proliferative disorders: delineation from immunologic diseases and non–mast cell hematopoietic neoplasmsJournal of Allergy and Clinical Immunology, 2004
- Systemic MastocytosisAnnual Review of Medicine, 2004
- Mastocytosis: current concepts in diagnosis and treatmentAnnals of Hematology, 2002